Luchowski Alicia T, Anderson Britta L, Power Michael L, Raglan Greta B, Espey Eve, Schulkin Jay
Long-Acting Reversible Contraception Program, The American College of Obstetricians and Gynecologists, Washington, DC.
Research Department, The American College of Obstetricians and Gynecologists, Washington, DC.
Contraception. 2014 Jun;89(6):578-83. doi: 10.1016/j.contraception.2014.02.004. Epub 2014 Feb 18.
Long-acting reversible contraception (LARC) - the copper and levonorgestrel intrauterine devices (IUDs) and the single-rod implant - are safe and effective but account for a small proportion of contraceptive use by US women. This study examined obstetrician-gynecologists' knowledge, training, practice and beliefs regarding LARC methods.
A survey questionnaire was mailed to 3000 Fellows of the American College of Obstetricians and Gynecologists. After exclusions, 1221 eligible questionnaires were analyzed (45.8% response rate, accounting for exclusions).
Almost all obstetrician-gynecologists reported providing IUDs (95.8%). Most obstetrician-gynecologists reported requiring two or more visits for IUD insertion (86.9%). Respondents that reported IUD insertion in a single visit reported inserting a greater number of IUDs in the last year. About half reported offering the single-rod implant (51.3%). A total of 92.0% reported residency training on IUDs, and 50.8% reported residency training on implants. Residency training and physician age correlated with the number of IUDs inserted in the past year. A total of 59.6% indicated receiving continuing education on at least one LARC method in the past 2years. Recent continuing education was most strongly associated with implant insertion, and 31.7% of respondents cited lack of insertion training as a barrier.
Barriers to LARC provision could be reduced if more obstetrician-gynecologists received implant training and provided same-day IUD insertion. Continuing education will likely increase implant provision.
This study shows that obstetrician-gynecologists generally offer IUDs, but fewer offer the single-rod contraceptive implant. Recent continuing education strongly predicted whether obstetrician-gynecologists inserted implants and was also associated with other practices that encourage LARC use.
长效可逆避孕法(LARC)——铜离子宫内节育器和左炔诺孕酮宫内节育器(IUDs)以及单棒式皮下埋植剂——安全有效,但在美国女性的避孕方式中占比很小。本研究调查了妇产科医生关于LARC方法的知识、培训、实践和观念。
向3000名美国妇产科医师学会会员邮寄了调查问卷。排除无效问卷后,对1221份合格问卷进行了分析(回复率为45.8%,含排除情况)。
几乎所有妇产科医生都报告提供宫内节育器(95.8%)。大多数妇产科医生报告宫内节育器置入需要两次或更多次就诊(86.9%)。报告单次就诊置入宫内节育器的受访者称去年置入的宫内节育器数量更多。约一半医生报告提供单棒式皮下埋植剂(51.3%)。共有92.0%的医生报告在住院医师培训期间接受过宫内节育器相关培训,50.8%的医生报告接受过皮下埋植剂相关培训。住院医师培训和医生年龄与过去一年置入的宫内节育器数量相关。共有59.6%的医生表示在过去两年中至少接受过一种LARC方法的继续教育。近期的继续教育与皮下埋植剂置入关联最为紧密,31.7%的受访者将缺乏置入培训视为障碍。
如果更多妇产科医生接受皮下埋植剂培训并提供当日宫内节育器置入服务,LARC方法的推广障碍可能会减少。继续教育可能会增加皮下埋植剂的提供。
本研究表明,妇产科医生普遍提供宫内节育器,但提供单棒式避孕皮下埋植剂的较少。近期的继续教育强烈预示着妇产科医生是否会置入皮下埋植剂,并且还与其他鼓励使用LARC的实践相关。